UNSPSC 51433508: Mibefradil hydrochloride

This classification denotes a calcium channel blocker with the molecular formula C29H38FN3O3.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 842TUP3PQ8, chemically known as acetic acid, methoxy-, 2-(2-((3-(1h-benzimidazol-2-yl)propyl)methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-(1-methylethyl)-2-naphthalenyl ester, dihydrochloride, (1s-cis)- but more generally known as mibefradil dihydrochloride, which bears US NIH Compound Identifier 60662.

European Medicines Agency schedules Mibefradil dihydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20668. Most nations, for tariff and trade purposes, schedule mibefradil hydrochloride under HS 29339990 and SITC 51577. SMILES: CC(C)[C@H]1C2CCC(CC2CC[C@@]1(CCN(C)CCCC3[NH]C4CCCCC4N3)OC(=O)COC)F.CL.CL.

UNSPSC 51433508 Mibefradil hydrochloride is a Commodity code representing specific pharmaceutical products—in this case, a particular cardiac medication—that state and local governments procure for emergency medical services, healthcare facilities, and public health programs. State and local buying under this code spans municipal fire-rescue departments, state health agencies, and cooperative purchasing alliances that aggregate demand across multiple jurisdictions. The actual scope of work involves supplying FDA-compliant pharmaceutical products with certified manufacturing practices, maintaining strict expiration-date and shelf-life requirements, arranging for timely delivery and expired-material replacement, providing comprehensive safety documentation including Safety Data Sheets compliant with OSHA standards, and demonstrating supply-chain security compliance. Issuing bodies include city purchasing departments procuring for emergency medical services, state health agencies managing pharmacy benefits programs, and multistate cooperative purchasing vehicles distributing products to participating government entities across multiple states.

The code shows recent activity across Florida, Texas, and Minnesota. The City of Tampa's Purchasing Department issued IFB 26P00188 in April 2026 for Advanced Life Support Medications (due April 8, 2026, estimated contract value $40,000.00) requiring four specific medication line items for Tampa Fire Rescue with nine-month minimum expiration dates and ten-day delivery, with a Small Local Business Enterprise sheltered-market 5 percent bid discount available. The Texas Health and Human Services Commission issued RFI HHS0017013 in March 2026 exploring vendor capacity for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and wholesaler channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities in Minnesota and Oregon, with proposals due March 26, 2026, requiring vendor relationships with three authorized wholesalers and compliance with cGMP and Drug Supply Chain Security Act standards.